Get the Stockscreener App
1.63
1.21%
-0.02
After Hours:
1.63
China Pharma Holdings Inc. stock is traded at $1.63, with a volume of 10,427.
It is down -1.21% in the last 24 hours and down -10.24% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$1.65
Open:
$1.66
24h Volume:
10,427
Relative Volume:
0.41
Market Cap:
$8.19M
Revenue:
$5.54M
Net Income/Loss:
$-4.74M
P/E Ratio:
-4.8512
EPS:
-0.336
Net Cash Flow:
$-750.60K
1W Performance:
+5.84%
1M Performance:
-10.24%
6M Performance:
-26.58%
1Y Performance:
-17.05%
1-Day Range:
$1.61
$1.66
1-Week Range:
$1.4901
$1.66
52-Week Range:
$1.20
$3.35
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
1.63 | 8.29M | 5.54M | -4.74M | -750.60K | -0.336 |
|
ZTS
Zoetis Inc
|
127.69 | 56.36B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.52 | 45.81B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.76 | 43.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
26.32 | 28.67B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
488.43 | 20.92B | 3.08B | 1.24B | 1.07B | 25.61 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Why Keysight Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Earnings Chart Overlay Points to International Travel House Limited UpsideEarnings Revision Updates & Free Turn Volatility To Profit - earlytimes.in
Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature’s Signal Transduction and Targeted Therapy - Yahoo Finance Singapore
Why China Pharma Holdings Inc. stock could be next leaderGlobal Markets & Weekly Momentum Picks - newser.com
How China Pharma Holdings Inc. stock compares with top peersJuly 2025 Fed Impact & Smart Investment Allocation Tips - newser.com
Is China Pharma Holdings Inc. stock vulnerable to regulatory risksMarket Movers & Verified Technical Signals - newser.com
Can China Pharma Holdings Inc. (XQJ0) stock retain market dominanceTrade Analysis Summary & Verified Entry Point Detection - newser.com
Why China Pharma Holdings Inc. stock appears on watchlists2025 Big Picture & High Conviction Buy Zone Picks - newser.com
Published on: 2025-11-20 06:20:45 - newser.com
Does China Pharma Holdings Inc. qualify in momentum factor screeningJuly 2025 Selloffs & Short-Term High Return Ideas - newser.com
Why China Pharma Holdings Inc. stock is upgraded to buyQuarterly Performance Summary & Risk Adjusted Swing Trade Ideas - newser.com
How strong dollar benefits China Pharma Holdings Inc. stockFed Meeting & Daily Growth Stock Tips - newser.com
Why China Pharma Holdings Inc. stock is trending on social mediaIndex Update & Weekly Top Stock Performers List - newser.com
What insider purchases suggest about China Pharma Holdings Inc. (XQJ0) stockMarket Movement Recap & High Accuracy Buy Signal Tips - newser.com
What momentum indicators show for China Pharma Holdings Inc. stock2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com
Published on: 2025-11-20 00:39:09 - newser.com
Will China Pharma Holdings Inc. stock issue positive guidanceTrade Entry Summary & Daily Growth Stock Investment Tips - newser.com
Is China Pharma Holdings Inc. stock a buy for dividend portfoliosWeekly Trend Report & AI Powered Market Entry Ideas - newser.com
How supply shortages influence China Pharma Holdings Inc. (XQJ0) stock2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com
What Wall Street predicts for China Pharma Holdings Inc. stock priceMarket Volume Summary & Safe Capital Growth Trade Ideas - newser.com
Why China Pharma Holdings Inc. is moving todayJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - newser.com
How strong dollar benefits China Pharma Holdings Inc. (XQJ0) stock2025 Technical Overview & Fast Momentum Entry Tips - newser.com
Does China Pharma Holdings Inc. stock trade below intrinsic valueJuly 2025 Breakouts & Expert-Curated Trade Recommendations - newser.com
Key resistance and support levels for China Pharma Holdings Inc.2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
Can China Pharma Holdings Inc. stock hit record highs againPortfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Published on: 2025-11-19 13:13:39 - newser.com
Published on: 2025-11-19 12:46:47 - newser.com
What catalysts could drive China Pharma Holdings Inc. stock higher2025 Short Interest & High Return Trade Guides - newser.com
What technical models suggest about China Pharma Holdings Inc.’s comebackJuly 2025 Setups & Risk Managed Investment Signals - newser.com
Published on: 2025-11-19 06:23:42 - newser.com
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.53%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):